EB Securities 2025 Internet Media Investment Strategy: Emotional Consumption, Content Renaissance
In the competitive landscape of the domestic market, platform companies are in a relatively advantageous position, maintaining a "buy" rating for the internet media industry.
EB Securities released a research report stating that with the national economy gradually emerging from the trough and entering into a period of structural recovery, residents are focusing more on emotional consumption in their spending habits. The virtual economy is expected to grow faster than the physical economy, providing broad market space and development opportunities for the internet media sector. In the competitive landscape of domestic demand, platform companies are in a relatively favorable position, maintaining a "buy" rating for the internet media industry.
EB Securities' main points are as follows:
Internet: with slowing traffic, strong potential in local life under weak overall consumption recovery, internet platforms are competitive and will seek to exceed expectations in profit optimization.
Game: although user growth is gradually reaching its peak, there are still various player demands that have not been fully met.
IP Derivatives: with a positive outlook, the industry chain's leading position remains stable.
Film and Television: current expectations are pessimistic, with a focus on future improvements in supply.
Music: with a stable competitive landscape, the industry is expected to have continuous volume and price increases.
Risk Warning: risks include declining popularity in e-commerce live streaming, underperformance in new international game business, underperformance in IP derivative monetization, and lower-than-expected box office performance in the film and television industry.
Related Articles

Financial activities nourish the fields, not delaying the farming season - HARBIN BANK is fully committed to supporting the spring farming production in 2026.

CSTONE PHARMA-B(02616): Sugelizumab Recommended Again in ESMO Guidelines [I, A] - Used for Consolidation Treatment of Stage III Non-Small Cell Lung Cancer

BATELAB (02149) releases annual performance with a profit of 122 million yuan for the year, a decrease of 26.8% year-on-year.
Financial activities nourish the fields, not delaying the farming season - HARBIN BANK is fully committed to supporting the spring farming production in 2026.

CSTONE PHARMA-B(02616): Sugelizumab Recommended Again in ESMO Guidelines [I, A] - Used for Consolidation Treatment of Stage III Non-Small Cell Lung Cancer

BATELAB (02149) releases annual performance with a profit of 122 million yuan for the year, a decrease of 26.8% year-on-year.

RECOMMEND

Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026

Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026

Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026


